Intravesical chemotherapy for carcinoma in situ of the urinary bladder: 5 years later.
46 patients with carcinoma in situ of the urinary bladder were treated with intracavitary chemotherapy. The mean follow-up was 33 months. Tumor remission, defined by negative cytology and no evidence of TIS or severe dysplasia on biopsy, was achieved in 78%. There were 6 deaths, but only 1 was due to bladder cancer. 22 patients were followed after the termination of the planned treatment protocol. Recurrence of carcinoma in situ or development of a superficial bladder cancer was observed in 10 (45%). Bladder biopsies performed at the end of treatment were of no predictive value with regard to tumor recurrence. Tumor remission was achieved in all patients who received repeated intracavitary chemotherapy.